Barry A. Bunin
Collaborative Drug Discovery, USA
Received: July 05, 2022; Accepted: July 12, 2022; Published: July 20, 2022
Collaborative Drug Discovery (CDD) provides a whole solution for today’s biological and chemical data needs, differentiated by ease-of-use and superior collaborative capabilities. CDD Vault® software includes Activity & Registration, Visualization, Inventory, and ELN capabilities. Researchers can archive, mine, and securely collaborate within CDD Vault. Collaborative hypothesis generation and evaluation allow multiple perspectives for multi-parameter optimization. CDD’s Research Informatics Group invents bleeding edge technologies. For example, the recently developed BioHarmony data store provides real-time semantic drug reports. In addition, BioHarmony Annotator allows more sophisticated assay registration and management. Case studies will be shared from industry (Jubilant Biosys), government (NIH Neuroscience Blueprint), non-profit (Gates Foundation), and numerous leading academic collaborations. Patients (n=15) who did not require prerepair intervention, did not have post-repair complication and did not require intervention in follow up had better QoL (PCS 63 vs 51, MCS 82 vs 56, p<0.03) than those (n=32) who required pre-repair intervention, had post-repair complication, required intervention in follow up; their mental Qol (MCS 82 vs 98 p=0.08) was similar to those who underwent uncomplicated LC (n=50).